To assess whether serum LL37 reflects renal crescentic formation, we measured the serum levels of LL37 in AAV patients with and without crescentic glomerulonephritis (crescentic GN) as compared to healthy controls (HCs). This evidence concerns the gene CAMP and anti-neutrophil cytoplasmic antibody-associated vasculitis.